Where does Neovasc Tiara Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Neovasc Tiara Inc. ranks #8,259 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Neovasc Tiara Inc. hold?

Neovasc Tiara Inc. holds 39 US utility patents granted between 2016 and 2025, spanning 4 technology areas.

What is Neovasc Tiara Inc.'s Innovation Score?

Neovasc Tiara Inc. has an Innovation Score of 44.4 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Neovasc Tiara Inc.'s patent grant rate increasing or decreasing?

Neovasc Tiara Inc.'s recent grant velocity is +64% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Neovasc Tiara Inc.'s patents?

Neovasc Tiara Inc.'s patents average 20.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Neovasc Tiara Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Neovasc Tiara Inc.

Q: What technology areas does Neovasc Tiara Inc. focus on?

Neovasc Tiara Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 38 patents, ranking #165 of 3,082 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 39 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neovasc ranks #8,259 of 49,997 tracked US assignees by granted-patent volume, with 39 patents across 4 technology areas.

#8,259
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.4/100): 20.9
avg claims per patent: +64%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8259 · Foreign Corporation #8,259 · 39 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 39 grants
UPPER-Q #8,259/49,997
PHOTO-FINISH Newpark Mats &…
CPC-NARROW A61F · 4 areas
INNOV-PAR 44.4/100
CLAIMS-DENSE 20.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +64% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Newpark Mats & Integrated Services LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neovasc’s 44.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (29%) Velocity 12.0 pts (27%) Breadth 7.1 pts (16%) Claim depth 12.5 pts (28%)

Qualcomm Incorporated · highest

85
Industry Academic… · near

44
Leuze + KG · near

44
Neovasc Tiara · this assignee

44
Unimatec · near

44
Entrust Datacard · near

44
3D Lighting… · lowest

7

What this shows Neovasc's Innovation Score is 44.4/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Neovasc?

Each dot is one of Neovasc’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neovasc’s own 20.9 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Neovasc vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neovasc's grants concentrate

Neovasc Tiara Inc. is a focused PatentsView assignee: 4 CPC subclasses with 97.4% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2022 (7 grants) versus a trough of 1 in 2018. By volume, Neovasc sits between Newpark Mats & Integrated Services LLC and Oklahoma Medical Research Foundation.

Neovasc's three-year grant acceleration

Neovasc Tiara Inc. shows 18 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Newpark Mats & In…

39
Nippon Piston Ring

39
Nittoh

39
Novadelta—COMÉRCI…

39
Nexa3d

39
Nuwave

39
Oxford Instrument…

39
Oklahoma Medical…

39
Neovasc Tiara ◀

39

What this shows Neovasc holds 39 patents at rank #8,264, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Neovasc

By rank, the assignees closest to #8,264 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Neovasc's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Neovasc, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Neovasc ranks #165 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Unimatec Co., Ltd. 44 Leuze electronic GmbH + Co. KG 44 Industry Academic Cooperation Foundation OF Yeungnam University 44 Entrust Datacard Corporation 44

Neovasc's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Neovasc Tiara Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	4	10.3%
2017	4	10.3%
2018	1	2.6%
2019	5	12.8%
2020	4	10.3%
2021	1	2.6%
2022	7	17.9%
2023	5	12.8%
2024	6	15.4%
2025partial year	2	5.1%

Which technologies does Neovasc Tiara Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 38

Y10T - Technical Subjects Covered BY Former US Classification 6

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Neovasc Tiara Inc.'s patent record in context - here's where to go next.

Neovasc Tiara Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 97.4% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #8,259 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Neovasc Tiara Inc. against Newpark Mats & Integrated Services LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.